Panacea Index Logo

Command Palette

Search for a command to run...

Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome.

Nutrition, metabolism, and cardiovascular diseases : NMCD
February 1, 2011
P Casas-Agustench et al. (6 authors)
Journal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to assess the effects of nut intake on metabolic syndrome components, including adiposity, serum lipids, insulin resistance, and inflammatory biomarkers.

Results Summary

The study found that a nut-supplemented diet improved insulin sensitivity and reduced fasting insulin and HOMA-insulin resistance, but did not significantly affect LDL-cholesterol compared to the control diet. Inflammatory markers like IL-6 showed improvement with the nut diet, though significance was attenuated after adjusting for weight loss.

Population

50 patients with metabolic syndrome (MetS).

Effective Dosage

30 g/day of mixed nuts (15 g walnuts, 7.5 g almonds, 7.5 g hazelnuts).

Duration

12 weeks.

Interactions

None mentioned.

Extracted Claims (11)
InterventionDirectionEndpointPopulationDosageImpactClaim #
healthy diet recommendations
decrease
weight
patients with MetS
-
Moderate weight loss
#1
healthy diet recommendations
decrease
adiposity
patients with MetS
-
decreased
#2
healthy diet recommendations
decrease
blood pressure
patients with MetS
-
lower
#3
Control diet (healthy diet recommendations without nuts)
decrease
LDL-cholesterol
patients with MetS
-0.36 mmol/L
significant reduction
#4
Nut diet (healthy diet recommendations with 30 g/day of raw nuts)
decrease
fasting insulin
patients with MetS
-2.60 μU/mL
reduced
#5
Nut diet (healthy diet recommendations with 30 g/day of raw nuts)
decrease
HOMA-insulin resistance
patients with MetS
-0.72
reduced
#6
Nut diet (healthy diet recommendations with 30 g/day of raw nuts)
decrease
plasma IL-6
patients with MetS
-1.1 ng/L
resulted in changes
#7
Control diet (healthy diet recommendations without nuts)
decrease
stool fat
patients with MetS
-
decreased
#8
Nut diet (healthy diet recommendations with 30 g/day of raw nuts)
increase
stool fat
patients with MetS
-
slightly increased
#9
daily intake of 30 g of mixed nuts
decrease
lipid responsiveness
patients with MetS
-
decreased lipid responsiveness
#10
daily intake of 30 g of mixed nuts
increase
insulin sensitivity
patients with MetS
-
improved
#11
Abstract

BACKGROUND AND AIMS: Knowledge of the effect of nut consumption on metabolic syndrome (MetS) components is limited. We assessed the effects of nut intake on adiposity, serum lipids, insulin resistance, and inflammatory biomarkers in patients with MetS. METHODS AND RESULTS: In a randomized, parallel-group, 12-week feeding trial, 50 patients with MetS were given recommendations for a healthy diet with or without supplementation with 30 g/day of raw nuts (15 g walnuts, 7.5 g almonds and 7.5 g hazelnuts) (Nut and Control diet groups, respectively). Adiposity measures, serum lipids, insulin, Homeostasis Model Assessment (HOMA), interleukin-6 (IL-6) and other inflammatory biomarkers, and 48-h fecal fat were determined basally and at study's completion. Moderate weight loss, decreased adiposity, and lower blood pressure occurred similarly after both diets. The Control, but not the Nut diet, was associated with significant (P<0.05) reduction of LDL-cholesterol, with mean changes of -0.36 versus -0.13 mmol/L, respectively (between-group differences, P=0.154). The Nut diet reduced fasting insulin by 2.60 μU/mL (95% CI, -4.62 to -0.59) and HOMA-insulin resistance by 0.72 (-1.28 to -0.16) (P<0.05 versus Control diet; both). Among inflammatory markers, the Nut diet resulted in changes of median plasma IL-6 of -1.1 ng/L (-2.7 to -0.1; P=0.035 versus Control diet), but adjustment for weight loss attenuated the significance of the association. Stool fat decreased with the Control diet and slightly increased with the Nut diet (P<0.05 for between-group differences). CONCLUSION: Patients with MetS show decreased lipid responsiveness but improved insulin sensitivity after daily intake of 30 g of mixed nuts.

Medical Subject Headings (MeSH)
AdiposityAdultAnalysis of VarianceBiomarkersBlood GlucoseCholesterol, LDLDietEnergy MetabolismFemaleHumansInflammationInsulinInsulin ResistanceInterleukin-6Linear ModelsMaleMetabolic SyndromeMiddle AgedNutsObesity
Study Links
Quality Scores
Safety90
Efficacy75/10
Quality85/10
Citation Metrics
Total Citations161
Citations/Year11.5
Relative Citation Ratio5.69
NIH Percentile94.4%
Research Impact Scores
APT Score0.95
Weight Score1.60
Normalized Score0.83
Related Supplements